Growth Metrics

Catalyst Pharmaceuticals (CPRX) EBT Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 32.79%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 47.54%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -49.71%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 12.01%
7 Evaxion A 62.56 Bn 62.54 Bn - 20.92%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1.05%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 48.67%
10 Catalyst Pharmaceuticals 3.82 Bn 3.07 Bn 134.92 Mn 31.18%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 31.18%
Dec 31, 2025 29.63%
Sep 30, 2025 39.79%
Jun 30, 2025 34.87%
Mar 31, 2025 59.83%
Dec 31, 2024 79.56%
Sep 30, 2024 59.60%
Jun 30, 2024 51.95%
Mar 31, 2024 43.32%
Dec 31, 2023 74.94%
Sep 30, 2023 -73.68%
Jun 30, 2023 67.12%
Mar 31, 2023 50.09%
Dec 31, 2022 57.77%
Sep 30, 2022 22.24%
Jun 30, 2022 35.28%
Mar 31, 2022 207.55%
Dec 31, 2021 42.34%
Sep 30, 2021 55.98%
Jun 30, 2021 67.10%
Mar 31, 2021 55.14%
Dec 31, 2020 53.53%
Sep 30, 2020 68.80%
Jun 30, 2020 67.25%
Mar 31, 2020 61.62%
Dec 31, 2019 58.99%
Sep 30, 2019 77.59%
Jun 30, 2019 65.06%
Mar 31, 2019 50.72%
Dec 31, 2018 -35.60%
Sep 30, 2018 -20.78%
Jun 30, 2018 -9.38%
Mar 31, 2018 -1.75%
Dec 31, 2017 -15.57%
Sep 30, 2017 5.88%
Jun 30, 2017 -6.65%
Mar 31, 2017 -9.23%
Dec 31, 2016 -45.39%
Sep 30, 2016 12.55%
Jun 30, 2016 -13.27%
Mar 31, 2016 -45.62%
Dec 31, 2015 -323.45%
Sep 30, 2015 -19.28%
Jun 30, 2015 -150.77%
Mar 31, 2015 -70.62%
Dec 31, 2014 -14.06%
Sep 30, 2014 -64.38%
Jun 30, 2014 -31.88%
Mar 31, 2014 -35.94%
Dec 31, 2013 -22.96%
Sep 30, 2013 -87.01%